Posted: February 2017
Peter Hammerman has been appointed Global Head, Oncology Translational Research at Novartis Institutes for BioMedical Research (NIBR). Previous to this appointment, Dr. Hammerman was a Medical Oncologist and Physician Scientist at Dana-Farber Cancer Institute and Assistant Professor, Medicine, Harvard Medical School, Boston, US.
